Acumen Research and Consulting, a global provider of market research studies, in a recently published report titled “Kidney Dialysis Market – Global Industry Analysis, Market Size, Opportunities and Outlook, 2020-2027”
LOS ANGELES, 23 March 2021 (GLOBE NEWSWIRE) – The Kidney World Dialysis Market it is expected to grow at a CAGR of around 5.7% from 2020 to 2027 and reach a market value of over US $ 96.5 Bn by 2027.
North America has controlled the renal dialysis market share from the past and is expected to continue the same trend in the coming years. On the other hand, the Asia-Pacific renal dialysis market is expected to rise at the fastest pace. This is reinforced by the fact that Asia-Pacific is one of the key markets for hemodialysis and peritoneal dialysis. China, India, and Japan are the key countries in APAC that have grown rapidly due to factors such as rising per capita revenues, improved healthcare infrastructure, and government support initiatives. . In addition, increased uptake of home hemodialysis and peritoneal dialysis, as well as an increase in an aging population and increased incidence of ESRD, are driving the global renal dialysis market forward.
PAGES SAMPLE DOWNLOAD THIS REPORT @ https://www.acumenresearchandconsulting.com/request-sample/2512
Market dynamics
The number of end-stage renal disease (ESRD), advanced technologies, and an increase in cost-effective and accurate portable dialysis equipment are the factors driving the growth of global renal dialysis market. According to estimates published by the University of California San Francisco in 2018, approximately 2 million people worldwide suffered from ESRD. Thus, as the disease is more common among the patient pool it directs the demand for renal dialysis equipment. Ultimately, this will strengthen the demand for a quick but effective treatment option for the population suffering from the disease.
Segmental Preview
The renal dialysis market is segmented by product, application and end user. Based on output, it is segregated as hemodialysis (HD) equipment, peritoneal dialysis (PD) equipment, compact & solutions, catheters & tubing, and others. By application, the market is bilateral such as hemodialysis and peritoneal dialysis. In addition, the end user is categorized into internal dialysis settings and home care settings.
COMMENT TABLE TABLE OF CONTENTS REPORT OF THIS REPORT @ https://www.acumenresearchandconsulting.com/kidney-dialysis-market
Based on results, hemodialysis (HD) equipment will have a major impact on the renal dialysis market in the coming years. This is due to the high frequency of renal failure in patients. Hemodialysis (HD) equipment is very specialized in filtering waste and water from the blood. Therefore, manufacturers are strongly focusing on the development of specialized hemodialysis equipment that is driving the growth of the global renal dialysis market.
Competitive Landscape
The key players involved in the renal dialysis market include Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, B. Braun, Becton, Dickinson and Company, Nipro Corporation, Medtronic plc, Nikkiso Co., Ltd., Asahi Kasei Medical Co., Limited, Cantel Medical Corporation, and among others.
Browse upcoming market research reports @ https://www.acumenresearchandconsulting.com/forthcoming-reports
Some of the key ideas regarding the renal dialysis market include:
- In November 2020, Baxter International Inc. gets approval for its new product even, “Homechoice Claria automated peritoneal dialysis system (APD)”. The new product is supported by a shared source link platform. This license recently expires in the End-Stage Renal Disease Treatment Option (ESRD) (ETC) payment model, aimed at significantly increasing the number of patients suffering from with renal failure receiving home dialysis or organ transplantation.
- In July 2018, Becton, Dickinson and Company announced the acquisition of TVA Medical, Inc. , a company involved in the development of a minimally invasive viral access solution for patients with kidney disease requiring hemodialysis. The build enables BD to offer a new product “everlinQ ™ endoAVF System”, an arteriovenous endovascular fistula (AV) formation technology that complements the company’s ESRD package of dialysis receptors, drug-covered balloons, conventional angioplasty balloons and products endovascular stent graft. technology further enhances BD’s ability to serve physicians and their patients by providing a small aggressive option for creating emergency AV fistulas (combining arteries to veins to create a circuit) for methods of hemodialysis.
- In January 2017, B. Braun announced obtaining Food and Drug Administration (FDA) approval for his new hemodialyzer, “Diacap Pro”. This newly developed “Diacap Pro” is designed to improve dialysis dose. The product specializes in purifying blood toxins such as urea ad creatinine, by retaining essential molecules such as albumin.
SEARCH FOR PURCHASE https://www.acumenresearchandconsulting.com/inquiry-before-buying/2512
Purchase THIS PREMIUM RESEARCH REPORT – https://www.acumenresearchandconsulting.com/buy-now/0/2512
If you would like to place any order or question, please contact us at [email protected] | +1 407 915 4157
For the latest update Follow us:
https://www.facebook.com/acumenresearchandconsulting
https://www.linkedin.com/company/acumen-research-and-consulting